Shree Pacetronix Ltd

Shree Pacetronix Ltd, a key player in the healthcare services sector, has seen its investment rating downgraded from Hold to Sell as of 19 Feb 2026. This shift reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite strong long-term fundamentals and impressive returns over the past year, recent technical indicators and valuation metrics have prompted a more cautious stance from analysts.

Shree Pacetronix Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Shree Pacetronix Ltd, a key player in the healthcare services sector, has seen its investment rating upgraded from Sell to Hold as of 2 February 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but optimistic outlook for investors amid a challenging market environment.

Shree Pacetronix Ltd, a notable player in the Healthcare Services sector, has seen its investment rating downgraded from Hold to Sell as of 28 January 2026. This shift is primarily driven by a deterioration in technical indicators, despite the company’s robust financial performance and attractive valuation metrics. Investors are advised to carefully consider the interplay of quality, valuation, financial trends, and technical signals before making investment decisions.

Shree Pacetronix Ltd, a key player in the healthcare services sector, has seen its investment rating upgraded from Sell to Hold as of 27 January 2026. This revision reflects a combination of improved technical indicators, robust financial trends, attractive valuation metrics, and sustained quality performance. Despite a recent dip in share price, the company’s long-term fundamentals and market-beating returns underpin a more optimistic outlook for investors.

Shree Pacetronix Ltd, a key player in the Healthcare Services sector, has seen its investment rating downgraded from Hold to Sell as of 20 Jan 2026. This shift is primarily driven by a deterioration in technical indicators, despite the company’s robust financial performance and attractive valuation metrics. The downgrade reflects a nuanced assessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals.

Shree Pacetronix Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 07 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Shree Pacetronix Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 01 Nov 2025. While this rating change occurred nearly two months ago, the analysis and financial metrics presented here reflect the company’s current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook.

Shree Pacetronix, a microcap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting recent developments in its financial and technical parameters. This shift highlights evolving perspectives on the company’s operational quality, valuation, financial trends, and technical outlook, providing investors with a refreshed understanding of its market position.

Shree Pacetronix has captured market attention with extraordinary buying momentum, registering a 2.0% gain today and maintaining an unbroken string of consecutive gains over the past three sessions. The stock’s unique trading pattern, characterised by an absence of sellers and a persistent upper circuit, signals a potential multi-day rally in the healthcare services sector.

Shree Pacetronix Ltd, a key player in the Healthcare Services sector, has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and an order book filled exclusively with buy orders. This rare market phenomenon signals robust investor enthusiasm and raises the prospect of a sustained multi-day circuit scenario.

Shree Pacetronix Ltd has attracted remarkable buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This unusual market activity signals strong investor confidence and the potential for a sustained multi-day circuit scenario.

Shree Pacetronix Ltd is experiencing significant selling pressure, with the stock hitting a lower circuit and an absence of buyers on the trading day. The healthcare services company’s shares have recorded consecutive losses, underperforming both its sector and the broader market indices, signalling distress selling and heightened market caution.

Shree Pacetronix Ltd has encountered significant selling pressure on 1 December 2025, with the stock registering a decline of 1.85% and exhibiting a rare scenario of exclusively sell orders in the queue. This distress selling signals heightened investor caution as the stock continues a nine-day losing streak, contrasting sharply with the broader market's modest gains.

Shree Pacetronix Ltd is currently experiencing significant selling pressure, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. The healthcare services company has recorded a continuous decline over the past eight trading sessions, signalling distress selling and heightened market caution.

Shree Pacetronix Ltd has encountered significant selling pressure, with the stock registering a continuous decline over the past week and no buyers present in the market today. The healthcare services company’s shares have been locked at the lower circuit, reflecting distress selling and a lack of demand amid a challenging trading session.

Shree Pacetronix Ltd has encountered significant selling pressure today, with the stock registering a lower circuit and an absence of buyers in the queue. The healthcare services company has recorded a continuous decline over the past six trading sessions, signalling distress selling and heightened market caution.

Shree Pacetronix Ltd has encountered significant selling pressure in recent sessions, with the stock registering a continuous decline over the past five days. The absence of buyers today has resulted in a lower circuit scenario, signalling distress selling within the Healthcare Services sector.